Top

Published in:

01-07-2015 | Research

A critical Analysis of the Relationship Between Aldehyde dehydrogenases-2 Glu487Lys Polymorphism and Colorectal Cancer Susceptibility

Authors: Bo Chen, Kong-Wang Hu, Jia-Wei Zhang, Zhi-Jian Wei, Xiang-Ling Meng, Mao-Ming Xiong

Published in: Pathology & Oncology Research | Issue 3/2015

Abstract

Studies investigating the association between genetic polymorphism of aldehyde dehydrogenases-2 (ALDH-2) Glu487Lys and colorectal cancer (CRC) risk have reported conflicting results. Given this uncertainty, we carried out a critical analysis of published case-control studies to derive a more precise estimation of this relationship. Published literature from PubMed, EMBASE and China Knowledge Resource Integrated Database were retrieved, and the literature search was updated in June 2014. Eleven studies comprising 6965 subjects were selected (2300 cases and 4665 controls). Overall, our study showed no statistical significance for CRC risk associated with any of the genetic models of ALDH-2 Glu487Lys polymorphism. When studies were stratified for control source, a decreased risk of CRC for participants with Lys/Lys was observed in population based case-control studies [Lys/Lys vs. (Glu/Lys + Glu/Glu): odds ratio (OR) = 0.57, 95% confidence interval (CI) = 0.38–0.87]. Furthermore, we also confirmed the significant correlation between Glu487Lys polymorphism and the influence on the risk of rectal cancer in males [Glu/Glu vs. (Glu/Lys + Lys/Lys): OR = 1.52, 95%CI = 1.10–2.08]. The combined effects of the two gene polymorphisms [ALDH-2 and alcohol dehydrogenase 1B (ADH-1B)] were also studied. Compared with subjects having ALDH-2 Lys+ with ADH-1B His/His, ORs and 95%CIs for those with ALDH-2 Glu/Glu and ADH-1B His/His was 3.42(0.57–20.38). Similar trends were observed for the other two types of comparisons. Our study supports that ALDH-2 Glu487Lys polymorphism is associated with significant reduced risks of CRC in population-based samples, and of rectal cancer in males.

Siegel R, Desantis C, Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64:104–117CrossRefPubMed

Durko L, Malecka-Panas E (2014) Lifestyle modifications and colorectal cancer. Curr Colorectal Cancer Rep 10:45–54CrossRefPubMedCentralPubMed

Zhang A, Sun H, Yan G, Wang P, Han Y, Wang X (2014) Metabolomics in diagnosis and biomarker discovery of colorectal cancer. Cancer Lett 345:17–20CrossRefPubMed

Church D, Midgley R, Kerr D (2012) Biomarkers in early-stage colorectal cancer: ready for prime time? Dig Dis 30(Suppl 2):27–33CrossRefPubMed

Haas SL, Ye W, Lohr JM (2012) Alcohol consumption and digestive tract cancer. Curr Opin Clin Nutr Metab Care 15:457–467CrossRefPubMed

Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Holmberg L, Kim DH, Malila N, Miller AB, Pietinen P, Rohan TE, Sellers TA, Speizer FE, Willett WC, Wolk A, Hunter DJ (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140:603–613CrossRefPubMed

Jarosz M, Sekula W, Rychlik E (2013) Trends in dietary patterns, alcohol intake, tobacco smoking, and colorectal cancer in polish population in 1960–2008. Biomed Res Int 2013:183204CrossRefPubMedCentralPubMed

Bongaerts BW, de Goeij AF, Wouters KA, van Engeland M, Gottschalk RW, Van Schooten FJ, Goldbohm RA, van den Brandt PA, Weijenberg MP (2011) Alcohol consumption, alcohol dehydrogenase 1c (adh1c) genotype, and risk of colorectal cancer in the netherlands cohort study on diet and cancer. Alcohol (Fayetteville, NY) 45:217–225CrossRef

Kim J, Cho YA, Kim DH, Lee BH, Hwang DY, Jeong J, Lee HJ, Matsuo K, Tajima K, Ahn YO (2012) Dietary intake of folate and alcohol, mthfr c677t polymorphism, and colorectal cancer risk in korea. Am J Clin Nutr 95:405–412CrossRefPubMed

10.

Yin G, Morita M, Ohnaka K, Toyomura K, Hamajima N, Mizoue T, Ueki T, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Terasaka R (2012) Genetic polymorphisms of xrcc1, alcohol consumption, and the risk of colorectal cancer in japan. J Epidemiol / Jpn Epidemiol Assoc 22:64–71CrossRef

11.

Chen K, Jiang Q, Ma X, Li Q, Yao K, Yu W, Zheng S (2005) Alcohol drinking and colorectal cancer: a population-based prospective cohort study in china. Eur J Epidemiol 20:149–154CrossRefPubMed

12.

Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Cogliano V, Group WHOIAfRoCMW (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8:292–293CrossRefPubMed

13.

Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, Group WHOIAfRoCMW (2009) A review of human carcinogens–part e: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10:1033–1034CrossRefPubMed

14.

Yoshida A, Rzhetsky A, Hsu LC, Chang C (1998) Human aldehyde dehydrogenase gene family. Eur J Biochem / FEBS 251:549–557CrossRef

15.

Crous-Bou M, Rennert G, Cuadras D, Salazar R, Cordero D, Saltz Rennert H, Lejbkowicz F, Kopelovich L, Monroe Lipkin S, Bernard Gruber S, Moreno V (2013) Polymorphisms in alcohol metabolism genes adh1b and aldh2, alcohol consumption and colorectal cancer. PLoS One 8:e80158CrossRefPubMedCentralPubMed

16.

Wu M, Chang SC, Kampman E, Yang J, Wang XS, Gu XP, Han RQ, Liu AM, Wallar G, Zhou JY, Kok FJ, Zhao JK, Zhang ZF (2013) Single nucleotide polymorphisms of adh1b, adh1c and aldh2 genes and esophageal cancer: a population-based case-control study in china. Int J Cancer J Int Cancer 132:1868–1877CrossRef

17.

Wang HL, Zhou PY, Liu P, Zhang Y (2014) Aldh2 and adh1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis. PLoS One 9:e88779CrossRefPubMedCentralPubMed

18.

Zhao H, Liu KJ, Lei ZD, Lei SL, Tian YQ (2014) Meta-analysis of the aldehyde dehydrogenases-2 (aldh2) glu487lys polymorphism and colorectal cancer risk. PLoS One 9:e88656CrossRefPubMedCentralPubMed

19.

Guo XF, Wang J, Yu SJ, Song J, Ji MY, Zhang JX, Cao Z, Wang J, Dong WG (2013) Meta-analysis of the adh1b and aldh2 polymorphisms and the risk of colorectal cancer in east asians. Intern Med 52:2693–2699CrossRefPubMed

20.

Tsutsumi M, Takase S, Takada A (1993) Genetic factors related to the development of carcinoma in digestive organs in alcoholics. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1B:21–26

21.

Yokoyama A, Muramatsu T, Ohmori T, Yokoyama T, Okuyama K, Takahashi H, Hasegawa Y, Higuchi S, Maruyama K, Shirakura K, Ishii H (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in japanese alcoholics. Carcinogenesis 19:1383–1387CrossRefPubMed

22.

Murata M, Tagawa M, Watanabe S, Kimura H, Takeshita T, Morimoto K (1999) Genotype difference of aldehyde dehydrogenase 2 gene in alcohol drinkers influences the incidence of japanese colorectal cancer patients. Japan J Cancer Res: Gann 90:711–719CrossRef

23.

Matsuo K, Hamajima N, Hirai T, Kato T, Koike K, Inoue M, Takezaki T, Tajima K (2002) Aldehyde dehydrogenase 2 (aldh2) genotype affects rectal cancer susceptibility due to alcohol consumption. J Epidemiol / Jpn Epidemiol Assoc 12:70–76CrossRef

24.

Otani T, Iwasaki M, Hanaoka T, Kobayashi M, Ishihara J, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Yoshimura K, Yoshida T, Tsugane S (2005) Folate, vitamin b6, vitamin b12, and vitamin b2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in japan. Nutr Cancer 53:42–50CrossRefPubMed

25.

Matsuo K, Wakai K, Hirose K, Ito H, Saito T, Suzuki T, Kato T, Hirai T, Kanemitsu Y, Hamajima H, Tajima K (2006) A gene-gene interaction between aldh2 glu487lys and adh2 his47arg polymorphisms regarding the risk of colorectal cancer in japan. Carcinogenesis 27:1018–1023CrossRefPubMed

26.

Jiang A, Gao C, Wu J, Takezaki T, Cao J, Tajima K, Shen H (2007) Association between adh2/aldh2 genetic polymorphism and habit of alcohol drinking and the susceptibility of rectal cancer. Chin J Cancer Prev Treat 14:1445–1449

27.

Yin G, Kono S, Toyomura K, Moore MA, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Imaizumi N (2007) Alcohol dehydrogenase and aldehyde dehydrogenase polymorphisms and colorectal cancer: the fukuoka colorectal cancer study. Cancer Sci 98:1248–1253CrossRefPubMed

28.

Yang H, Zhou Y, Zhou Z, Liu J, Yuan X, Matsuo K, Takezaki T, Tajima K, Cao J (2009) A novel polymorphism rs1329149 of cyp2e1 and a known polymorphism rs671 of aldh2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern chinese population. Cancer Epidemiol Biomarkers Prev 18:2522–2527

29.

Miyasaka K, Hosoya H, Tanaka Y, Uegaki S, Kino K, Shimokata H, Kawanami T, Funakoshi A (2010) Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer. Geriatr Gerontol Int 10(Suppl 1):S120–S126CrossRefPubMed

30.

Chiang CP, Jao SW, Lee SP, Chen PC, Chung CC, Lee SL, Nieh S, Yin SJ (2012) Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human large bowel: association of the functional polymorphisms of adh and aldh genes with hemorrhoids and colorectal cancer. Alcohol (Fayetteville, NY) 46:37–49CrossRef

31.

Chen B, Cao L, Yang P, Zhou Y, Wu XT (2012) Cyclin d1 (ccnd1) g870a gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects. Cancer Epidemiol 36:106–115CrossRefPubMed

32.

Zakhari S (2006) Overview: how is alcohol metabolized by the body? Alcohol Res Health: J Natl Inst Alcohol Abus Alcohol 29:245–254

33.

Druesne-Pecollo N, Tehard B, Mallet Y, Gerber M, Norat T, Hercberg S, Latino-Martel P (2009) Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 10:173–180CrossRefPubMed

34.

Gao CM, Takezaki T, Wu JZ, Zhang XM, Cao HX, Ding JH, Liu YT, Li SP, Cao J, Matsuo K, Hamajima N, Tajima K (2008) Polymorphisms of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 and colorectal cancer risk in chinese males. World J Gastroenterol : WJG 14:5078–5083CrossRefPubMedCentralPubMed

35.

Mulligan CJ, Robin RW, Osier MV, Sambuughin N, Goldfarb LG, Kittles RA, Hesselbrock D, Goldman D, Long JC (2003) Allelic variation at alcohol metabolism genes (adh1b, adh1c, aldh2) and alcohol dependence in an american indian population. Hum Genet 113:325–336CrossRefPubMed

Title: A critical Analysis of the Relationship Between Aldehyde dehydrogenases-2 Glu487Lys Polymorphism and Colorectal Cancer Susceptibility
Authors: Bo Chen
Kong-Wang Hu
Jia-Wei Zhang
Zhi-Jian Wei
Xiang-Ling Meng
Mao-Ming Xiong
Publication date: 01-07-2015
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 3/2015
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-014-9881-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

Susceptibility to Gastric Cancer and Polymorphisms of Insertion/Deletion at the Intron 3 of the XRCC4 and VNTR at the Promoter Region of the XRCC5

HMCN1, a cell polarity-related gene, is somatically mutated in gastric and colorectal cancers

Association of Romo1 Gene Genetic Polymorphisms with Risk of Gastric Cancer in Northwestern Chinese Population

GNAS Mutation Affecting Codon 201 is Rare in Most Human Tumors

Altered MicroRNA Expression in Folliculotropic and Transformed Mycosis Fungoides

CD44-SLC1A2 Fusion Transcripts in Primary Colorectal Cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer